Rocuronium plasma concentrations during three phases of liver transplantation: Relationship with early postoperative graft liver function

British Journal of Anaesthesia

Volumn 88, Issue 6, 2002, Pages 764-770

  Gao, L ^a   Ramzan, I ^a   Baker, B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Liver, function; Liver, Transplantation; Neuromuscular block, Rocuronium; Pharmacokinetics, rocuronium

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; ISOFLURANE; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM; SUXAMETHONIUM; THIOPENTAL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INFUSION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GAS CHROMATOGRAPHY; GRAFT SURVIVAL; HUMAN; LIVER DISEASE; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; MASS SPECTROMETRY; PARALYSIS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0036273571     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/88.6.764     Document Type: Article

References (16)

1. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl
2. The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat
3. Relationship between chemical structure and physicochemical properties of series of bulky organic cations and their hepatic uptake and biliary excretion rates
4. Clinical pharmacology of rocuronium (Org 9426): Study of the time course of action, dose requirement, reversibility, and pharmacokoinetics
5. Urinary, biliary and faecal excretion of rocuronium in humans
6. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation
7. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure
8. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis
9. Duration of rocuronium-induced neuromuscular block during liver transplantation: A predictor of primary allograft function
10. Vecuronium neuromuscular blockade reflects liver function during hepatic autotransplantation in pigs
11. Dose requirements of vecuronium, pancuronium, and atracurium during orthotopic liver transplantation
12. Duration of vecuronium-induced neuromuscular block as a predictor of liver allograft dysfunction
13. Pharmacokinetics of rocuronium during the three stages of liver transplantation
14. Transection of the oesophagus for bleeding oesophageal varices
15. Gas chromatographic-mass spectrometric assay for rocuronium with potential for quantifying its metabolite, 17-desacetylrocuronium, in human plasma
16. Clinical assessment of neuromuscular transmission